Hydroxyl-HIST1H4A (Y88) Antibody

Shipped with Ice Packs
In Stock

Description

Validation and Specificity

The antibody’s specificity is critical for reliable results:

  • Cross-reactivity: No reported cross-reactivity with unmodified Tyr88 or other histone H4 modifications (e.g., acetylated or methylated residues) based on peptide array screening .

  • Validation Data:

    • WB: Detects a ~11 kDa band corresponding to histone H4 in human cell lysates .

    • IF/ICC: Localizes to nuclei in human cell lines (e.g., HeLa), consistent with histone H4’s role in chromatin .

    • ELISA: Effective at concentrations ranging from 1:100 to 1:1000 dilutions .

Research Context and Biological Significance

While the functional role of Y88 hydroxylation in histone H4 remains under investigation, studies on analogous histone PTMs provide insights:

  • Epigenetic Regulation: Histone H4 modifications (e.g., acetylation, phosphorylation) influence chromatin structure and gene expression . Hydroxylation may similarly modulate DNA accessibility or protein interactions.

  • Comparative Studies: Antibodies against phosphorylated Tyr88 (pY88-H4) have been used to map androgen receptor (AR) gene regulation in prostate cancer, highlighting the importance of tyrosine modifications in disease pathways .

Limitations and Best Practices

  • Specificity Challenges: Antibodies targeting PTMs require rigorous validation due to potential cross-reactivity with structurally similar epitopes . The Histone Antibody Specificity Database (source 8) recommends verifying antibodies using peptide microarrays.

  • Application Guidelines:

    • WB: Use 1:100–1:1000 dilution with human cell lysates .

    • IF/ICC: Optimize between 1:50–1:500 .

Future Directions

Further research is needed to:

  • Map genome-wide occupancy of Y88-hydroxylated H4 using chromatin immunoprecipitation (ChIP-seq).

  • Investigate crosstalk between hydroxylation and other histone modifications (e.g., acetylation or methylation).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your orders. Delivery times may vary depending on the purchasing method or location. For specific delivery times, please consult your local distributors.
Synonyms
dJ160A22.1 antibody; dJ160A22.2 antibody; dJ221C16.1 antibody; dJ221C16.9 antibody; FO108 antibody; H4 antibody; H4.k antibody; H4/a antibody; H4/b antibody; H4/c antibody; H4/d antibody; H4/e antibody; H4/g antibody; H4/h antibody; H4/I antibody; H4/j antibody; H4/k antibody; H4/m antibody; H4/n antibody; H4/p antibody; H4_HUMAN antibody; H4F2 antibody; H4F2iii antibody; H4F2iv antibody; H4FA antibody; H4FB antibody; H4FC antibody; H4FD antibody; H4FE antibody; H4FG antibody; H4FH antibody; H4FI antibody; H4FJ antibody; H4FK antibody; H4FM antibody; H4FN antibody; H4M antibody; HIST1H4A antibody; HIST1H4B antibody; HIST1H4C antibody; HIST1H4D antibody; HIST1H4E antibody; HIST1H4F antibody; HIST1H4H antibody; HIST1H4I antibody; HIST1H4J antibody; HIST1H4K antibody; HIST1H4L antibody; HIST2H4 antibody; HIST2H4A antibody; Hist4h4 antibody; Histone 1 H4a antibody; Histone 1 H4b antibody; Histone 1 H4c antibody; Histone 1 H4d antibody; Histone 1 H4e antibody; Histone 1 H4f antibody; Histone 1 H4h antibody; Histone 1 H4i antibody; Histone 1 H4j antibody; Histone 1 H4k antibody; Histone 1 H4l antibody; Histone 2 H4a antibody; histone 4 H4 antibody; Histone H4 antibody; MGC24116 antibody
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, restricting access to cellular machineries that require DNA as a template. Consequently, histones play a crucial role in regulating transcription, DNA repair, DNA replication, and maintaining chromosomal stability. DNA accessibility is regulated through a complex interplay of post-translational modifications of histones, collectively known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Studies have shown that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Research indicates that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac upon DNA double-strand break, requiring the participation of SETD2, LEDGF, and KAT5 (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5). PMID: 28546430
  3. Data suggest that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be linked to an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation induced by hypoxia in human neuroblastoma cell lines corresponds to elevated levels of N-myc transcription factor. PMID: 24481548
  9. Data indicate that histone assembly during the G1 phase is restricted to CENP-A and H4. PMID: 23363600
  10. This study investigated the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its enrichment sites in promoters throughout the human genome. PMID: 22894908
  11. SRP68/72 heterodimers are identified as major nuclear proteins whose binding of histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to an epigenetic mechanism involving suppression of acetylation of histone H4. PMID: 21973049
  13. Research suggests that global histone H3 and H4 modification patterns are potential markers for tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially affects nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47, catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing association of CAF-1 with H3.1-H4. PMID: 21724829
  16. Imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4 modifications. PMID: 20949922
  17. Our findings reveal the molecular mechanisms by which DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which subsequently reduces gene expression by half. PMID: 20512922
  18. Histone H4 expression is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alterations in gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation levels of histone H4 protein are closely correlated. PMID: 15095300
  21. Peptidylarginine deiminase 4 regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. A link exists between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation play novel roles in mediating the recruitment of multiple regulatory factors that can alter chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 exists as a monomer in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common feature of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The interaction between SET8 and PCNA couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are crucial for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more prevalent in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Our findings suggest a significant role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results indicate that acetylation of histone H4 K16 during S-phase allows early replicating chromatin domains to acquire the H4K16ac-K20me2 epigenetic label that persists through mitosis and is deacetylated in early G1-phase of the subsequent cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma compared to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 through holocrine secretion from the sebaceous gland may play a significant role in innate immunity. PMID: 19536143
  37. Histone modifications, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cell reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36, two marks of elongation within genes, when the kinase was inhibited. PMID: 19667075
  39. Data revealed dynamic fluctuations in histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is the Hydroxyl-HIST1H4A (Y88) Antibody and what epitope does it recognize?

The Hydroxyl-HIST1H4A (Y88) Antibody is a research-grade monoclonal antibody specifically designed to recognize and bind to the hydroxylated tyrosine 88 residue on histone H4. This antibody typically recognizes a specific epitope containing the hydroxylated Y88 residue within its surrounding amino acid sequence. The specificity of this antibody is critical for distinguishing between hydroxylated and non-hydroxylated forms of Y88, allowing researchers to investigate this particular post-translational modification in various experimental contexts.

Unlike antibodies targeting acetylated residues such as the Anti-Acetyl-Histone H4 (Lys5) antibody described in the search results , the Hydroxyl-HIST1H4A (Y88) Antibody targets a different type of modification (hydroxylation) and a distinct residue (Y88) on the histone H4 protein. This specificity makes it a valuable tool for investigating the unique biological roles of tyrosine hydroxylation in chromatin regulation.

How does tyrosine hydroxylation at Y88 differ from other histone modifications?

Tyrosine hydroxylation at Y88 of histone H4 represents a distinct post-translational modification compared to more extensively studied modifications such as acetylation, methylation, or phosphorylation. Unlike acetylation at lysine residues (such as K5 on histone H4 ), which neutralizes the positive charge and generally promotes open chromatin structures, tyrosine hydroxylation introduces a polar hydroxyl group that can alter protein-protein interactions and DNA binding properties through hydrogen bonding capabilities.

The functional implications of Y88 hydroxylation differ from those of other modifications in several important ways:

Modification TypeCommon ResiduesFunctional ImpactDetection Methods
AcetylationLysine (K)Neutralizes positive charge; promotes open chromatinWestern blot, ChIP, mass spectrometry
MethylationLysine (K), Arginine (R)Variable effects depending on position and degreeWestern blot, ChIP, mass spectrometry
PhosphorylationSerine (S), Threonine (T), Tyrosine (Y)Adds negative charge; alters protein interactionsWestern blot, ChIP, mass spectrometry
HydroxylationTyrosine (Y)Alters hydrogen bonding; affects protein interactionsWestern blot, ChIP-seq, mass spectrometry

Unlike well-characterized modifications such as H4K5 acetylation, the full biological significance of Y88 hydroxylation remains an active area of investigation, requiring highly specific antibodies for accurate detection and characterization.

What experimental techniques can be effectively utilized with the Hydroxyl-HIST1H4A (Y88) Antibody?

The Hydroxyl-HIST1H4A (Y88) Antibody can be employed across multiple experimental techniques to investigate tyrosine hydroxylation in various research contexts. Based on the applications of similar histone modification antibodies , the following techniques are particularly suitable:

  • Western Blotting (WB): For quantitative analysis of global Y88 hydroxylation levels in cell or tissue lysates. Typical dilutions would range from 1:500 to 1:2000, depending on antibody concentration and specificity.

  • Immunocytochemistry (ICC)/Immunofluorescence (IF): For visualizing the nuclear localization and distribution patterns of hydroxylated H4Y88 in fixed cells. This approach allows for correlation with other nuclear markers or histone modifications.

  • Chromatin Immunoprecipitation (ChIP): For identifying genomic regions associated with hydroxylated H4Y88, providing insights into its potential role in gene regulation.

  • Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of hydroxylated H4Y88 levels in purified histone preparations or nuclear extracts.

  • Luminex-based multiplex assays: For simultaneous detection of multiple histone modifications, including H4Y88 hydroxylation, allowing for correlation studies between different epigenetic marks.

Each application requires specific optimization steps to ensure sensitivity and specificity, particularly given the relatively low abundance of tyrosine hydroxylation compared to other histone modifications.

How should Western blot protocols be optimized for detecting hydroxylated H4Y88?

Western blot protocols for detecting hydroxylated H4Y88 require specific optimization steps to ensure sensitivity and specificity. Based on standard practices for histone modification antibodies:

  • Sample preparation:

    • Use histone extraction protocols that preserve hydroxylation modifications

    • Consider using histone deacetylase inhibitors (like sodium butyrate) and protease inhibitors in lysis buffers

    • Include antioxidants (e.g., sodium ascorbate) to prevent oxidation of hydroxyl groups

  • Gel electrophoresis:

    • Use 15-18% SDS-PAGE gels to achieve good separation of the low molecular weight histone proteins

    • Load appropriate amount of histones (typically 5-15 μg of acid-extracted histones)

  • Transfer and blocking:

    • Use PVDF membranes for optimal protein binding

    • Consider wet transfer at low voltage (30V) overnight at 4°C for efficient transfer of small proteins

    • Block with 5% BSA in TBST rather than milk (milk contains phosphoproteins that may interfere)

  • Antibody incubation:

    • Use optimized antibody dilution (typically 1:1000 for primary antibody)

    • Incubate overnight at 4°C with gentle rocking

    • Include phosphatase inhibitors in antibody dilution buffers

  • Detection:

    • Use high-sensitivity ECL substrates due to potentially low abundance of the hydroxylation mark

    • Consider longer exposure times than typically used for more abundant modifications

These optimization steps should be adjusted based on the specific properties of the Hydroxyl-HIST1H4A (Y88) Antibody and the experimental system being studied.

How can researchers validate the specificity of Hydroxyl-HIST1H4A (Y88) Antibody?

Validating antibody specificity is crucial for ensuring reliable experimental results, particularly for antibodies targeting post-translational modifications. For the Hydroxyl-HIST1H4A (Y88) Antibody, several approaches can be used:

  • Peptide competition assays: Compare antibody binding with and without pre-incubation with:

    • Hydroxylated Y88 peptide (should block binding)

    • Unmodified Y88 peptide (should not block binding)

    • Peptides with other modifications at Y88 (should not block binding)

  • Knockout/knockdown validation:

    • Test antibody reactivity in cells where enzymes responsible for Y88 hydroxylation have been depleted

    • Use CRISPR/Cas9 to generate Y88F mutants (prevents hydroxylation) and confirm loss of antibody reactivity

  • Mass spectrometry correlation:

    • Perform ChIP-MS or immunoprecipitation followed by mass spectrometry to confirm the antibody is capturing the hydroxylated form of Y88

    • Compare antibody-based quantification with MS-based quantification of hydroxylation levels

  • Cross-reactivity testing:

    • Test against a panel of histone peptides with various modifications to ensure the antibody does not cross-react with other modified residues

    • Similar to validation reported for other histone modification antibodies , confirm no cross-reactivity with other hydroxylated tyrosine residues on histones

Proper validation experiments should be conducted and documented before using the antibody in critical research applications.

What controls should be included in experiments using Hydroxyl-HIST1H4A (Y88) Antibody?

Including appropriate controls is essential for interpreting results obtained with the Hydroxyl-HIST1H4A (Y88) Antibody. The following controls should be considered:

  • Technical controls:

    • No primary antibody control: To assess background from secondary antibody

    • Isotype control: Using an irrelevant antibody of the same isotype

    • Blocking peptide control: Pre-incubating the antibody with excess hydroxylated Y88 peptide

  • Biological controls:

    • Treatment controls: Cells treated with inhibitors of enzymes involved in tyrosine hydroxylation

    • Positive controls: Samples known to have high levels of Y88 hydroxylation

    • Negative controls: Y88F mutant histones or cells where hydroxylation is absent

  • Validation controls:

    • Secondary antibody-only controls for immunofluorescence

    • Input controls for ChIP experiments

    • Loading controls for Western blots (total H4 or another stable protein)

  • Cross-technique validation:

    • Confirm findings using alternative detection methods (e.g., mass spectrometry)

    • Use multiple antibody clones targeting the same modification if available

These controls help distinguish specific signal from background and validate the biological significance of the observed patterns of Y88 hydroxylation.

How can Hydroxyl-HIST1H4A (Y88) Antibody be effectively used in ChIP-seq experiments?

ChIP-seq using the Hydroxyl-HIST1H4A (Y88) Antibody can provide valuable insights into the genomic distribution of this modification and its potential role in gene regulation. Based on established protocols for histone modification ChIP-seq:

  • Chromatin preparation:

    • Optimize fixation conditions (typically 1% formaldehyde for 10 minutes)

    • Consider using dual crosslinking with additional protein-protein crosslinkers

    • Ensure appropriate sonication to generate 200-500 bp fragments

    • Include antioxidants in buffers to preserve hydroxyl modifications

  • Immunoprecipitation:

    • Determine optimal antibody amount through titration experiments (typically 2-5 μg per ChIP)

    • Use longer incubation times (overnight at 4°C)

    • Include specific blocking agents to reduce background

    • Perform stringent washes to remove non-specific binding

  • Library preparation and sequencing:

    • Use library preparation methods suitable for limited material

    • Consider using spike-in controls for quantitative comparisons

    • Aim for deeper sequencing (>30 million reads) due to potentially sparse genomic distribution

  • Data analysis considerations:

    • Use appropriate peak calling algorithms (e.g., MACS2 with parameters optimized for histone modifications)

    • Compare with distributions of other histone marks

    • Correlate with gene expression data to infer functional significance

    • Analyze motif enrichment to identify potential sequence preferences

This approach can reveal the genomic regions where Y88 hydroxylation occurs and provide insights into its potential regulatory functions.

What is the relationship between Y88 hydroxylation and other histone modifications?

Understanding the relationship between Y88 hydroxylation and other histone modifications is important for deciphering the "histone code." While specific research on Y88 hydroxylation interactions is emerging, general principles from histone modification studies suggest:

  • Co-occurrence patterns:

    • Certain modifications may positively correlate with Y88 hydroxylation (synergistic relationship)

    • Other modifications may negatively correlate (antagonistic relationship)

    • Sequential modifications may occur where one modification facilitates or inhibits Y88 hydroxylation

  • Functional interactions:

    • Y88 hydroxylation may influence the binding of reader proteins for other modifications

    • The hydroxyl group could form hydrogen bonds that alter chromatin structure

    • Hydroxylation could impact the activity of enzymes that add or remove other modifications

  • Integrated analysis approaches:

    • Mass spectrometry to identify co-occurring modifications on the same histone tail

    • Sequential ChIP (Re-ChIP) to identify genomic regions with multiple modifications

    • Correlative ChIP-seq analysis to identify patterns of co-occurrence genome-wide

Potential InteractionPossible MechanismExperimental Approach
H4K5 acetylation and Y88 hydroxylationStructural changes in histone tail affecting accessibilitySequential ChIP, mass spectrometry of modified histones
H4R3 methylation and Y88 hydroxylationPotential reader protein competitionIn vitro binding assays, structural studies
H3K9 methylation and H4Y88 hydroxylationPotential cross-talk in heterochromatin formationCorrelative ChIP-seq, fluorescence microscopy

Understanding these relationships requires integrative approaches combining multiple techniques and computational analyses.

What are common challenges in Hydroxyl-HIST1H4A (Y88) Antibody experiments and how can they be addressed?

Working with antibodies targeting histone modifications presents several challenges. For the Hydroxyl-HIST1H4A (Y88) Antibody, researchers may encounter:

  • Low signal intensity:

    • Increase antibody concentration or incubation time

    • Use signal amplification methods (e.g., TSA for immunofluorescence)

    • Optimize extraction methods to preserve hydroxylation

    • Include antioxidants in all buffers to prevent loss of hydroxyl groups

  • High background or non-specific binding:

    • Optimize blocking conditions (try different blocking agents: BSA, normal serum, commercial blockers)

    • Increase washing stringency (higher salt concentration, longer washes)

    • Pre-adsorb antibody with non-specific proteins

    • Use monovalent Fab fragments instead of complete IgG antibodies

  • Batch-to-batch variability:

    • Validate each new antibody lot against previous lots

    • Maintain reference samples for comparison

    • Consider producing large batches of antibody for long-term projects

  • Cross-reactivity issues:

    • Conduct thorough validation using peptide arrays

    • Use knockout/mutation controls

    • Consider alternative antibody clones or custom antibody development

  • Technical variability in ChIP experiments:

    • Standardize chromatin preparation methods

    • Include spike-in controls for normalization

    • Use automated systems for consistent sample handling

Addressing these challenges requires systematic optimization and careful experimental design.

How do sample preparation methods affect the detection of hydroxylated H4Y88?

Sample preparation significantly impacts the detection of histone modifications, particularly for potentially labile modifications like hydroxylation:

  • Cell/tissue lysis considerations:

    • Use denaturing conditions promptly to inactivate enzymes that might remove modifications

    • Include appropriate enzyme inhibitors (HDACs, phosphatases, proteases)

    • Add antioxidants to prevent oxidative damage to hydroxyl groups

    • Minimize exposure to freeze-thaw cycles

  • Histone extraction methods:

    • Acid extraction (0.2N HCl or 0.4N H2SO4) is generally suitable for preserving most modifications

    • Alternative: high-salt extraction with 420mM NaCl can be gentler for certain modifications

    • Avoid harsh detergents that might affect protein-protein interactions

  • Fixation for immunocytochemistry:

    • Optimize paraformaldehyde concentration and fixation time (typically 2-4% for 10-20 minutes)

    • Consider epitope retrieval methods if necessary (heat-induced or enzymatic)

    • Test alternative fixatives that may better preserve hydroxyl groups (e.g., Methanol/Acetone)

  • Storage considerations:

    • Store samples at -80°C with protease inhibitors and antioxidants

    • Minimize repeat freeze-thaw cycles

    • Consider preparing aliquots to avoid repeated handling of stock samples

  • Protein degradation prevention:

    • Add protease inhibitors freshly to all buffers

    • Work at 4°C whenever possible

    • Process samples quickly to minimize degradation time

Careful optimization of these parameters is essential for reliable and reproducible detection of hydroxylated H4Y88.

How is Hydroxyl-HIST1H4A (Y88) implicated in disease mechanisms and pathophysiology?

Emerging research suggests potential roles for histone tyrosine hydroxylation in various disease processes, though this area remains actively investigated:

  • Cancer biology:

    • Preliminary evidence suggests altered patterns of histone hydroxylation in certain cancer types

    • Changes in hydroxylation may affect gene expression programs involved in cell proliferation and metastasis

    • Potential therapeutic target through modulation of the enzymes controlling hydroxylation

  • Inflammatory disorders:

    • Possible links between oxidative stress, hydroxylation signaling, and inflammatory gene expression

    • Altered hydroxylation patterns may contribute to dysregulated immune responses

    • Understanding these connections may reveal new therapeutic approaches

  • Neurological disorders:

    • Brain tissue exhibits unique patterns of histone modifications

    • Y88 hydroxylation may play roles in neuronal gene expression and plasticity

    • Dysregulation could contribute to neurodegenerative or neurodevelopmental disorders

  • Metabolic diseases:

    • Connections between cellular metabolism, oxygen sensing, and histone hydroxylation

    • Potential role in metabolic adaptation and stress responses

    • May contribute to pathophysiology of metabolic syndrome and related disorders

Investigating these disease connections requires carefully validated antibodies and integrated multi-omics approaches to establish causative relationships rather than correlative observations.

What are the latest methodological advances for studying hydroxylated H4Y88 in single-cell contexts?

Single-cell approaches represent the cutting edge of epigenetic research, allowing for analysis of cellular heterogeneity in hydroxylation patterns:

  • Single-cell approaches:

    • Emerging single-cell ChIP-seq protocols can be adapted for hydroxylated H4Y88

    • CUT&Tag and CUT&RUN methods offer higher sensitivity for limited material

    • Mass cytometry (CyTOF) with metal-conjugated antibodies against hydroxylated H4Y88

    • Single-cell ATAC-seq combined with antibody-based enrichment for hydroxylated regions

  • Spatial technologies:

    • Imaging-based approaches like Imaging Mass Cytometry (IMC) to visualize hydroxylation in tissue context

    • Multiplexed immunofluorescence to correlate Y88 hydroxylation with other cellular markers

    • In situ sequencing approaches combined with antibody detection

  • Technical considerations for single-cell methods:

    • Antibody specificity becomes even more critical at single-cell resolution

    • Optimization of fixation and permeabilization for antibody accessibility

    • Development of spike-in controls and normalization methods for quantitative comparisons

    • Computational approaches for integrating hydroxylation data with other single-cell modalities

These advanced methods promise to reveal the heterogeneity and dynamics of Y88 hydroxylation at unprecedented resolution, potentially uncovering new biological insights that are masked in bulk population analyses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.